Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1c89ce4d9ac03f9acd8ddede1162f94d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D207-14 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D207-14 |
filingDate |
2020-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ecdb705f14c2cf7868f33049786fefeb http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9f40ed5413ec63df3e54bc10eabe288 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e738e8525f370a4b0b2d7b1d11892f0a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff36ee1af8cee1b1434b31382c147592 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2e07465f7ae946bcc943cb7601370368 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b7966d584c95c5cb8a2f64ca434fe014 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_80abbe5385fc9cc947406355cff111ea http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d72b11229071040e8d50032ae1807d0d |
publicationDate |
2022-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2022144771-A1 |
titleOfInvention |
Pyrrolidine orexin receptor agonists |
abstract |
The present invention is directed to pyrrolidine compounds which are agonists of orexin receptors. The present invention is also directed to uses of the compounds described herein in the potential treatment or prevention of neurological and psychiatric disorders and diseases in which orexin receptors are involved. The present invention is also directed to compositions comprising these compounds. The present invention is also directed to uses of these compositions in the potential prevention or treatment of such diseases in which orexin receptors are involved. |
priorityDate |
2019-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |